Senner Christopher J. 4

What Happened

• Christopher J. Senner, EVP and Chief Financial Officer of Exelixis, was granted 52,018 restricted stock units (RSUs) on February 26, 2026. The grant price reported is $0.00, so no cash was exchanged; the reported transaction code is "A" (award/grant).
• The RSUs will convert to common shares upon vesting. Per the filing, vesting occurs as to 1/4 of the original award on May 15, 2027 and then 1/4 on each May 15 thereafter until fully vested.

Key Details

• Transaction date: 2026-02-26; Form 4 filed: 2026-03-02 (timely).
• Transaction type/code: Award (A); shares granted: 52,018; price paid: $0.00.
• Shares owned after transaction: total post-transaction holdings are not explicitly stated on the Form 4. Footnotes indicate (F2) 479,708 shares that will be issued upon vesting of other RSUs/One-Time Award PSUs and (F3) shares held under the Exelixis 401(k) plan as of Feb 26, 2026.
• Footnote highlights: F1 = this grant’s RSUs and the vesting schedule; F2 = additional RSUs/PSUs (performance-based) that could convert to 479,708 shares upon vesting; F3 = 401(k) plan holdings.
• No tax-withholding or sell-to-cover details were disclosed in this filing.

Context

• RSUs are compensation awards that become company stock only when they vest; they are not an open-market purchase or sale and do not directly signal immediate buy/sell sentiment.
• PSUs (not part of this specific grant) are performance-contingent awards and convert to shares only if performance targets are met. This filing documents routine executive equity compensation rather than a cash transaction.